Hetero exports generic semaglutide to over 75 countries & more related News Here
Hyderabad: Pharma company Hetero on Friday said it has started exporting its generic semaglutide injection portfolio to more than 75 countries as part of a multi-year plan to expand access to type 2 diabetes and obesity treatment.The Hyderabad-based pharmaceutical company said initial rollouts are underway in Africa, Asia and the Middle East, with additional launches…